Shan Joseph 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed Nov 1, 2017
Insider Transaction Report
Form 4
Shan Joseph
VP Clin./Regulatory Affs. (3)
Transactions
- Other
Common Stock
2017-10-31$3.87/sh+2,747$10,624→ 16,187 total
Footnotes (1)
- [F1]Shares acquired under the issuer's employee stock purchase plan on October 31, 2017.